Rezultati - Tim Nichols
- Showing 1 - 3 results of 3
-
1
Breaching the DNA damage checkpoint via PF-00477736, a novel small-molecule inhibitor of checkpoint kinase 1 od Alessandra Blasina, Jill Hallin, Enhong Chen, Maria E. Arango, Eugenia Kraynov, James Register, Stephan K. Grant, Sacha Ninkovic, Ping Chen, Tim Nichols, Patrick M. O’Connor, Kenna Anderes
Izdano 2008Artigo -
2
[18F]FLT–PET Imaging Does Not Always “Light Up” Proliferating Tumor Cells od Cathy C. Zhang, Zhengming Yan, Wenlin Li, Kyle Kuszpit, Cory L. Painter, Qin Zhang, Patrick B. Lappin, Tim Nichols, Maruja E. Lira, Timothy Affolter, Neeta R. Fahey, Carleen Cullinane, Mary E. Spilker, Kenneth Zasadny, Peter J. O’Brien, Dana Buckman, Anthony Wong, James G. Christensen
Izdano 2011Artigo -
3
PF-06463922 is a potent and selective next-generation ROS1/ALK inhibitor capable of blocking crizotinib-resistant ROS1 mutations od Helen Y. Zou, Qiuhua Li, Lars D. Engstrom, Melissa West, Vicky A. Appleman, Katy A. Wong, Michele McTigue, Yali Deng, Wei Liu, Alexei Brooun, Sergei Timofeevski, Scott R. McDonnell, Ping Jiang, Matthew D. Falk, Patrick B. Lappin, Timothy Affolter, Tim Nichols, Wenyue Hu, Justine L. Lam, Ted W. Johnson, Tod Smeal, Al Charest, Valeria R. Fantin
Izdano 2015Artigo
Iskalna orodja:
Sorodne teme
Biology
Cancer research
Biochemistry
Cancer
Genetics
Medicine
Adenocarcinoma
Anaplastic lymphoma kinase
Antibody
Avidity
Biodistribution
Biomarker
Biotechnology
CHEK1
Carboplatin
Cell biology
Cell cycle
Cell cycle checkpoint
Cell growth
Checkpoint Kinase 2
Chemistry
Chemotherapy
Cisplatin
Crizotinib
DNA
DNA damage
DNA repair
G2-M DNA damage checkpoint
Gemcitabine
Gene